+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Flutamide (CAS 13311-84-7) Global Market Research Report 2024 - Product Thumbnail Image

Flutamide (CAS 13311-84-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Fludarabine (CAS 21679-14-1) Global Market Research Report 2024 - Product Thumbnail Image

Fludarabine (CAS 21679-14-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Gemcitabine (CAS 95058-81-4) Global Market Research Report 2024 - Product Thumbnail Image

Gemcitabine (CAS 95058-81-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Filgrastim (CAS 121181-53-1) Global Market Research Report 2024 - Product Thumbnail Image

Filgrastim (CAS 121181-53-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Fenretinide (CAS 65646-68-6) Global Market Research Report 2024 - Product Thumbnail Image

Fenretinide (CAS 65646-68-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Glycopyrrolate (CAS 596-51-0) Global Market Research Report 2024 - Product Thumbnail Image

Glycopyrrolate (CAS 596-51-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Aminopyrine (CAS 58-15-1) Global Market Research Report 2024 - Product Thumbnail Image

Aminopyrine (CAS 58-15-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Amifostine (CAS 20537-88-6) Global Market Research Report 2024 - Product Thumbnail Image

Amifostine (CAS 20537-88-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Fosfestrol (CAS 522-40-7) Global Market Research Report 2024 - Product Thumbnail Image

Fosfestrol (CAS 522-40-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Granisetron (CAS 109889-09-0) Global Market Research Report 2024 - Product Thumbnail Image

Granisetron (CAS 109889-09-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Axitinib (CAS 319460-85-0) Global Market Research Report 2024 - Product Thumbnail Image

Axitinib (CAS 319460-85-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Exisulind (CAS 59973-80-7) Global Market Research Report 2024 - Product Thumbnail Image

Exisulind (CAS 59973-80-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Everolimus (CAS 159351-69-6) Global Market Research Report 2024 - Product Thumbnail Image

Everolimus (CAS 159351-69-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Amrubicin (CAS 110267-81-7) Global Market Research Report 2024 - Product Thumbnail Image

Amrubicin (CAS 110267-81-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more